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Aim of the study 
The in vitro antiplasmodial activity and cytotoxicity of methanolic and dichloromethane extracts from 
five Congolese plants were evaluated. The plants were selected following an ethnobotanical survey 
conducted in D.R. Congo and focusing on plants used traditionally to treat malaria. The in vivo 
antimalarial activity of aqueous and methanolic extracts active in vitro was also determined in mice 
infected by Plasmodium berghei berghei. 
Materials and methods 
The growth inhibition of Plasmodium falciparum strains was evaluated using the 
measurement of lactate dehydrogenase activity. The extracts (aqueous, CH3OH, EtOH and 
CH2Cl2) were prepared by maceration and tested in vitro against the 3D7 (chloroquine sensitive) and 
W2 (chloroquine resistant) strains of Plasmodium falciparum and against the human normal fetal lung 
fibroblasts WI-38 to determine the selectivity index. Some extracts were also used at the dose of 
300mg/kg to evaluate their activity in mice infected since 4 days by Plasmodium berghei. 
Results 
Two plants presented a very high activity (IC50 < 3µg/ml). These plants were Strychnos icaja roots 
bark (MeOH and CH2Cl2) and  Physalis angulata  leaves (MeOH and CH2Cl2). One plant 
(Anisopappus chinensis whole plant, MeOH and CH2Cl2) presented a high activity (IC50 < 15µg/ml).  
The extracts of Anisopappus chinensis and Physalis angulata showed also a good inhibition of 
parasitemia in vivo. Flavonoids, phenolic acids and terpenes were identified in these plants by a 
general phytochemical screening method.  
Conclusion 
Three plants showed a very interesting antiplasmodial activity (Anisopappus chinensis, Physalis 
angulata, Strychnos icaja)   and one of them showed a good selectivity index ( >10,  Anisopappus 
chinensis). Anisopappus chinensis and Physalis angulata were also active in vivo. 
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1. Introduction 
Malaria is still a major public health problem, especially in tropical and sub-tropical regions. 
It is estimated that  half of the world population is still at risk of contracting malaria and an 
estimated 243 million cases led to nearly 863 000 deaths in 2008, mostly of African children 
aged below 5 years, who are the most susceptible to this disease. In Sub-Saharan regions, 45 
countries were endemic for malaria in 2008 (WHO, 2009).  
Democratic Republic of Congo is a tropical country located in central Africa where malaria with 
Plasmodium falciparum is highly endemic, being one of the most important health problems in the 
country. Since the 1960s, the spread of resistance to most antimalarials (choroquine, pyrimethamine, 
sulfadoxine, mefloquine, quinine) led to an evident need for new anti-malarial drugs, and 
medicinal plants constitute a reliable source of these, particularly in D.R. Congo where several 
plants are used alone or in combination by the population to treat malaria or other diseases.  
D.R.Congo is one of the richest countries in natural resources and the diversity of its botanicals 
resources is particularly important. Many medicinals plants growing in this area are not yet 
investigated. Furthermore, the ACT recommended in D.R.Congo is artesunate-amodiaquine, but 
the use of this drug is very limited in some rural areas where the population prefer traditional, 
less expensive preparations (WHO, 2009).  
 
Previously, a research program has been initiated by some of the authors for the evaluation of the 
antiamoebic and antiplasmodial activity of medicinal plants species traditionally used to treat amoebias 
and malaria in Congolese traditional medicine (Tona et al., 1998; Tona et al., 2000; Tona et al., 1999). 
Relying on this ethnobotanical survey conducted in D.R.Congo in 2000-2002, we selected five plants 
used in traditional medicine for treating malaria, fever, inflammation, amoebics, thyphoid fever… These 
plants were: Anisopappus chinensis Hook. & Arn. (Asteraceae), Entandrophragma palustre Staner 
(Meliaceae); Melia azedarach L. (Meliaceae), Physalis angulata L. (Solanaceae),   Strychnos icaja 
Baill. (Loganiaceae). The present study investigates the in vitro antiplasmodial activity of methanolic, 
aqueous and dichloromethane extracts of these plants against 3D7 (chloroquine sensitive) and W2 
(chloroquine resistant) strains of Plasmodium falciparum and the in vitro cytotoxicity of the same 
extracts against the human lungs fibroblasts WI-38. The more active in vitro plants were then selected 
for in vivo evaluation: aqueous and in some cases methanolic, ethanolic and dichloromethane extracts 
were tested  against Plasmodium berghei berghei. 
2. Material and methods 
 
2.1.  Plant material 
Plant samples were collected in different regions of D.R.Congo  (Table 1). They were identified by 
Mr N. Nlandu of the "Institut National d’Etudes et de Recherches en Agronomie" (INERA) from the 
University of Kinshasa. A voucher specimen for each plant was deposited in the herbarium of the 
institute and for two of them in the National Botanical Garden of Belgium (Meise, Belgium). All 
samples collected were air-dried at room temperature with no direct sunlight for three days. 
2.2.  Preparation of extracts 
Crude aqueous, methanolic and dichloromethane extracts were obtained by maceration of 4 g of each 
powdered plant sample three times in 30 ml of solvent, for 30 min under constant shaking at room 
temperature. For each solvent, a new plant sample was used separately. The extracts were filtered and 
evaporated to dryness under reduced pressure at 40°C with a rotatory evaporator. All extracts obtained 
were weighed and their yield calculated. Yields were respectively: 14.1% and 2.3% (A. chinensis 
MeOH and CH2Cl2); 59.0%  and 4.4% (E. palustre MeOH and CH2Cl2);  14.4% and 5.7% (M. 
azedarach MeOH and CH2Cl2);  22.6% and4.5% (P. angulata MeOH and CH2Cl2);  16.6% and 4.9% 
(S. icaja MeOH and CH2Cl2). 
2.3.    Phytochemical screening: 
Alkaloids, flavonoids, phenolic acids, terpenes and tannins were identified by TLC using a standard 
lab protocol (Wagner and Bladt, 1984).  
2.4. In vitro antiplasmodial assays 
 
The culture of Plasmodium falciparum strains was carried out as previously described method 
(Frédérich et al., 2001). All crude extracts were evaluated in vitro for their activity against a 
chloroquine-sensitive strain of Plasmodium falciparum (3D7) and the most active extracts 
were also evaluated against a chloroquine-resistant strain (W2). For each crude extract, a 
series of 8 threefold dilutions (from 200 to 0.09 µg/ml) was prepared, placed in 2 rows of a 
96-well microplate and tested in triplicate. Artemisinin (98%, Sigma-Aldrich) and 
Chloroquine diphosphate salt (Sigma-Aldrich) were used as standards, and infected and 
uninfected erythrocytes were added as positive and negative controls respectively.  After 48 
hours of incubation at 37 ºC, the level of parasitaemia was estimated by measuring lactate 
dehydrogenase activity, as previously described (Jonville et al., 2008). The results were 
expressed as the mean IC50 (the concentration of a drug that reduced the level of parasitaemia 
to 50%). 
 
2.5.  In vitro cytotoxic assay  
Cells from the human normal foetal lung fibroblast cell line, WI-38, were cultivated in vitro in 
DMEM: Dubecco’s Modified Eagle’s Medium (Lonzo, Belgium), which contains 5% of L-
glutamate (Lonzo, Belgium), 5% of penicillin-streptomycin (Lonzo, Belgium) and 10% of 
heat inactivated foetal bovine serum (Lonzo, Belgium). Then, the cells were incubated at 37 
ºC in a humidified atmosphere with 5% CO2. For each sample, 6 threefold dilutions (from 200 
to 0.82 µg/ml) were prepared, placed in 3 rows of a 96-well microplate and tested at least 
twice.  Camptothecin (Sigma) was used as a positive control. After 48 hours incubation, cell 
viability was determined by measuring the fibroblast mitochondrial enzyme activity, as 
previously described (Stevigny et al., 2002). The results were expressed by the mean of IC50s 
of at least 2 independent assays and the selectivity index (the ratio between the cytotoxic (WI-
38 cells) and antiparasitic (3D7 strain) activity) was calculated. 
2.6. In vivo antimalarial activity   
 
The in vivo antimalarial activity was determined using NMRI mice bred in the pet shop of the “Institut 
National de Recherches Biomédicales de Kinshasa (INRB)” with average weight of 23.9 gr  ± 4.2. 
Mice were infected by the rodent parasite Plasmodium berghei berghei (origin: Antwerp Tropical 
Medicine Institute) during 4 days (D1-D4). The treatment (oral) began at day 5 by using 300mg/kg 
body weight of each extract in solution in saline and was delivered during 4 days (D5-D8). 
Parasitaemia was determined at D8 and D9. Chloroquine (25 mg/kg) and quinine (20 mg/kg) were 
used as positive controls; saline was used as negative control. The method was previously described 
(Tona et al., 2001). Ethanolic extracts were prepared as previously described for other extracts. 
 
2.7. Statistics  
Differences between control and samples in the in vivo assay were compared by using the student’s T-
test. Statistical significance was fixed at p ≤ 0.05. 
3. Results and discussion 
 
According to WHO guidelines and previous results from our team (Jonville et al., 2008; Pink 
et al., 2005), antiplasmodial activity of extracts was classified as follows: highly active 
extracts with IC50 < 5 µg/ml, promising activity at 5-15 µg/ml, moderate activity at 15-50 
µg/ml and inactivity at > 50µg/ml. Among the five plants evaluated, three showed a significant 
antiplasmodial activity with an IC50 < 15μg/ml for their dichloromethane and methanolic extracts 
against the two strains of Plasmodium falciparum (A. chinensis, P. angulata and S. icaja ), and two 
were highly active.  E. palustre showed a moderate activity against the two strains of Plasmodium and 
M. azedarach showed a moderate activity against the two strains only for his dichloromethane extract 
(Table 2). The extracts with at least a promising level of activity (IC50 < 15 µg/ml) were then 
assessed for their cytotoxic activity in order to determine the selectivity index (see Table 2). 
The cytotoxic assay was performed on human lung fibroblasts (WI38). The SI is defined as the ratio of 
the cytotoxic IC50 value and the parasitic IC50 value. The cytotoxicity of several alkaloids from 
Strychnos icaja  and the cytotoxicity of  Physalis angulata extract were previously described  and 
showed, in this last case, a SI between 4 and 5 (Frederich et al., 2000; Frederich et al., 2001; Zirihi et 
al., 2005).  Anisopappus chinensis showed the higher SI for its methanolic and dichloromethane 
extracts, with values superior to 10. Aqueous extracts of active plants were then evaluated in vitro, P. 
angulata revealing a moderate activity and A. chinensis a very slight activity (> 50 µg/ml). The active 
extracts were finally evaluated for their in vivo activity, except for S. icaja, which contains strychnine 
and which was previously evaluated in vivo (Philippe et al., 2007). Aqueous extracts of active plants 
were first evaluated in vivo, as it is the preparation method used traditionally. The dose of 300 mg/kg 
was chosen according to WHO guidelines and previous lab experience (Fidock et al., 2004). As the 
aqueous extract of Physalis angulata caused a very significant inhibition of parasite growth (> 80 %), 
its methanolic, ethanolic and dichloromethanic extracts were also evaluated (Table 3). The active 
plants contained alkaloids, flavonoids, phenolic acids, terpenes, tannins (Table 4). 
3.1. Anisopappus chinensis Hook. & Arn. (Asteraceae), 
This savannah herb was harvested in Kolwezi, province of Katanga. Traditionally, an aqueous 
decoction of the whole plants or of the leaves is used to cure malaria, inflammation, thyphoid, pain 
and ulcer wounds. This work is the first report about the in vitro and in vivo antimalarial and cytotoxic 
activity of this plant which presented a promising activity, a relatively high selectivity index (> 10) 
and a very high activity in vivo including for the aqueous extract. The phytochemistry of this plant is 
completely unexplored.  
3.2. Entandrophragma palustre  Staner (Meliaceae) 
This forest and savannah tree was collected in the provinces Bas-Congo and Kasaï where an aqueous 
decoction of leaves or stem bark is used to treat malaria, inflammation,  rheumatism, stomachache and 
otitis. This work reports for the first time the moderate antiplasmodial and significant antimalarial 
(especially at D9) activity of this plant. The only phytochemical study conducted on this plant was 
realized in 1934 and showed the presence of catechol and tannins (Tihon, 1934). 
3.3. Melia azedarach  L. (Meliaceae),   
This shrub was collected in Maniema, in Bas-Congo provinces where an aqueous decoction of the 
leaves is used to cure malaria and thyphoid fever. In Asia , the extracts of fruits, leaves, stem are  used  
to cure filarisis,  the extract of fruits is used as an antifungal and insecticide,  the extract of leaves is 
used as an antiviral and the extract of flowers as an antibacterial of the skin; in Kenya, the plant is used 
as an antimalarial (Muregi et al., 2004; Saleem et al., 2008; Vishnukanta Rana, 2008). The 
antimalarial activity against a chloroquine sensitive strain was previously reported (Ofulla et al., 
1995). In this study, a moderate activity for the dichloromethane extract and a weak activity for the 
methanolic extract was shown against two strains of P. falciparum  (19 and 28 µg/ml and 55 / 46 
µg/ml, respectively). This plant was also active against the malaria vector Anopheles stephensi 
(Nathan et al., 2006).  This plant was the subject of several publications,  particularly concerning its 
insecticidal and pesticide properties. These properties were attributed to the presence of limonoids 
such as azadirachtin (Klocke et al., 1991). 
3.4. Physalis angulata  L. (Solanaceae),    
This herb is a food plant in D.R.Congo and an aqueous decoction of leaves or whole plant is used to 
cure malaria and inflammation. It is used to treat diabetes, hepatitis, asthma and malaria in Taiwan 
(Hsieh et al., 2006). Physalis angulata showed the stronger activity (with S. icaja) against the two 
strains of Plasmodium falciparum  (< 5µg/ml for all extracts), a SI between 4 and 5, and its aqueous 
extract was also active in vivo.  The in vitro antimalarial activity and the cytotxicity of this plant were 
previously reported (Hsieh et al., 2006; Kvist et al., 2006; Zirihi et al., 2005) but we obtained a better 
activity in the present study. The plant is also part of a four-plants decoction used in Ghana to treat 
malaria and active on rats (Ankrah et al., 2003). The compounds responsible for the activity are not yet 
known. Some limonoids were nevertheless shown to be active against leishmaniasis (Guimaraes et al., 
2009).  Other known compounds from P. angulata include whithanolides, withangulatins (steroidal 
lactones) and physalins (unusual steroids) (Damu et al., 2007). Some of these compounds are 
cytotoxic. 
  
3.5. Strychnos icaja Baill.(Loganiaceae) 
This forest shrub was found in the equatorial forest and is mainly  used as arrow poison (Philippe et 
al., 2004) but it is also used by pygmies in Cameroon to treat malaria (Neuwinger, 1996). This plant is 
well known in our lab and old samples, collected 50 years ago (Denoel et al., 1953),  have been 
studied for antiplasmodial properties. Several bisindole alkaloids were isolated from this plant and 
showed a high antiplasmodial and antimalarial activity (Frederich et al., 2000; Frederich et al., 2001; 
Frederich et al., 1999; Philippe et al., 2007). This study confirmed the activity of this plant on fresh 
samples.  
 
4. Conlusions  
 For the first time, a promising antiplasmodial and antimalarial activity with an interesting selectivity 
index was demonstrated for A.chinensis. This plant is particularly interesting for a further investigation 
as very few is known about its phytochemical composition. The antiplasmodial activities of P. 
angulata and S. icaja, previously known, were confirmed against two strains of Plasmodium 
falciparum . A moderate antiplasmodial and antimalarial activity was also identified for the first time 
for E. palustre. 
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Table 1 . List of selected plants, family, vernacular names, voucher number and specific parts used.  










Aspect   
Anisopappus chinensis Hook. 
& 
Arn 





r     
Meliaceae pake stem bark Oct-00 Kasai - 9287 tree 
Melia azedarach L. Meliaceae kamunara leaves Sept-07 Maniema - 141 shrub 





Strychnos icaja        Baill. Loganiaceae mbondo bololo root bark Febr-08 Equateur - 357 shrub        
 
Table 2 
Selectivity index (SI), in vitro IC50 values against Plasmodium falciparum (3D7and W2) and against 
WI-38 cells. 
Species or 
compound Plant part Extracts 3D7, IC50 µg/ml W2, IC50 µg/ml WI- 38 SI 
A. chinensis whole plant MeOH 8.82 ± 2.83 12.24 ± 1.91 126.33 ± 6.50 10.32 
    CH2Cl2 6.53 ± 1.33 6.37 ± 1.16 98.25 ± 19.32 15.42 
H2O 76.51±23.65 nd nd nd 
E. palustre Stem bark MeOH 15.84 ± 1,19 35.98 ± 4.61 nd nd 
    CH2Cl2 17.69 ± 2.16 23.18 ± 8.10 nd nd 
  H2O >100 nd nd nd 
M. azedarach leaves MeOH 55.13 ± 10.67 44.62 ± 3.22 nd nd 
    CH2Cl2 19.14 ± 10.15 28.10 ± 1.20 nd nd 
P. angulata whole plant MeOH 1.27 ± 0.25 3.02 ± 2.10 15.68 ± 1.11 5 
    CH2Cl2 1.96 ± 1.21 2.00 ± 0.08 7.84 ± 0.58 4 
H2O 23.10±1.18 nd nd nd 
S. icaja root bark MeOH 0.69 ± 0.25 0.42 ± 0.22 nd nd 
    CH2Cl2 0.84 ± 0.05 0.61 ± 0.35 nd nd 
       
Chloroquine -  - 0.0073±0.0022 0.0036±0.0006 nd nd 
Artemisinin - - 0.0024±0.00013 0.00172±0.00043 nd Nd 
camptothecin - - nd nd  0.0192±0.020 nd 
 
  
Table 3 : In vivo antimalarial activity (parasite growth inhibition) of extracts (300 mg/kg, oral), 
chloroquine (25 mg/kg, oral) and quinine (20 mg/kg, oral) on mice infected by Plasmodium berghei 
berghei.  
Plants Extracts or 
compound 










P. angulata aqueous PAQ 58.7 0.005 61.2 0.006 
P. angulata ethanolic PALC 43.4 0.005 61.6 0.010 
A. chinensis methanolic AM1 80.5 0.001 63.2 0.007 
A. chinensis ethanolic AALC 65.5 0.004 43.9 0.047 
A. chinensis dichloromethane ADCM 60.8 0.013 47.7 0.035 
A. chinensis aqueous AAQ 85.6 0.002 46.6 0.027 
E. palustre aqueous ENTAQ 52.2 0.036 73.3 0.034 
Pos. Control Chloroquine   80.0 0.002 100.0 0.0005 
Pos. Control Quinine   70.3 0.010 73.0 0.001 
  
Table 4. Results of phytochemical screening 
Plants Phytochemicals  
alkaloids flavonoids terpenes tannins Phenolic acids 
A. chinensis - + + + + 
E. palustre - - + + - 
M. azedarach - + + + - 
P. angulata - + + + + 




In vivo antimalarial activity (parasite growth inhibition) of extracts on mice infected by Plasmodium 
berghei berghei. 
 
Blue = D8  
Red = D9  
Dose of extract: 300mg/kg 
Quinine : 20mg/kg  
Chloroquine: 25mg/kg 
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